scispace - formally typeset
C

Cheng Gao

Researcher at University of Macau

Publications -  32
Citations -  949

Cheng Gao is an academic researcher from University of Macau. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 9, co-authored 18 publications receiving 414 citations. Previous affiliations of Cheng Gao include Wuhan University of Technology & Shenzhen University.

Papers
More filters
Journal ArticleDOI

Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines

TL;DR: Comparison to macrophage internalized with ROS-responsive NPs, as a live-cell based drug delivery system for treatment of atherosclerosis, suggests that cell membrane coated drug delivery approach is likely more suitable for dealing with an inflammatory disease than the live- cell approach.
Journal ArticleDOI

pH-Responsive prodrug nanoparticles based on a sodium alginate derivative for selective co-release of doxorubicin and curcumin into tumor cells

TL;DR: It is demonstrated that this novel pH-sensitive prodrug-nanoparticle system may provide a simple and efficient platform for the selective co-delivery of multiple drugs to tumor cells.
Journal ArticleDOI

A user-friendly herbicide derived from photo-responsive supramolecular vesicles

TL;DR: A photosensitive formulation that releases paraquat upon exposure to UV light or sunlight is generated, which shows an improved safety profile in zebrafish and mouse models, while maintaining substantial herbicidal activity.
Journal ArticleDOI

pH/redox responsive core cross-linked nanoparticles from thiolated carboxymethyl chitosan for in vitro release study of methotrexate.

TL;DR: A novel amphiphilic thiolated carboxymethyl chitosan synthesized into disulfide bond cross-linked nanoparticles in deionized water showed an obvious pH/redox responsibility, and may be used for tumor-specific drug release.
Journal ArticleDOI

Amelioration of ulcerative colitis via inflammatory regulation by macrophage-biomimetic nanomedicine

TL;DR: ThisMacrophage-biomimetic nanomedicine leverages the inflammatory tropism and inflammatory cytokine sequestration effects of macrophage membrane for targeted delivery and local inflammation suppression, the ROS-responsiveness of β-cyclodextrin-based matrix for specific payload release, and the macrophages-polarizing effect of rosiglitazone for inflammatory regulation, thereby exhibiting considerable therapeutic efficacy against UC in mice.